If the californian clinic follows the same regimine as for the phase1 trial patient with end stage renal cell carcinoma at Sir Charles Gardiner hospital in 2005,then the cycle will be.
a daily injection for 5 days and a break of 9 days.
After 6 cycles the 17mm tumour shrank by 50%
After 12 cycles the tumour had disappeared.
If this patient responds in a similar way,then I believe SBP is the best risk/reward situation on the market today!
- Forums
- ASX - By Stock
- SBP
- us patient
SBP
solbec pharmaceuticals limited
us patient
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online